Amomed Pharma GmbH
Amomed Pharma GmbH
Contact:
Beatrix Mick Schrempf
Phone: +43 1 545 01 13-26
E-Mail: b.mick-schrempf@amomed.com
KEYWORDS:
  • medical drugs
  • health
  • medicine
Download Photos
Amomed Pharma GmbH (100 releases)

A new therapeutic option for septic shock has now been approved for and is available in 26 European countries. Sepsis affects 27-30 million people and leads to eight million deaths worldwide every year. Septic shock is caused by a generalized bacterial infection and is associated with higher morbidity and mortality as well as extended invalidity. Most importantly, sepsis has negative effects on the cardiovascular system. Blood pressure drops, consciousness is clouded, the heart rate and respiratory rate increase. Worsened macro and micro-circulation leads to impaired blood flow to organs and ultimately to organ damage. [more]

New approaches to early identification of Parkinson's disease
2016-05-30, ptp20160530021 Health/Medicine, Science/Technology
Portuguese study did not find an increased stroke risk for football fans
2016-05-29, ptp20160529005 Health/Medicine, Sport/Events
Underestimated burden: epilepsy, multiple sclerosis, Parkinson's & Co impair sexuality
2016-05-29, ptp20160529004 Health/Medicine, Sport/Events
New findings on the connections between gut microbiota and the brain
2016-05-29, ptp20160529003 Health/Medicine, Sport/Events
WhatsApp-based support group likely to improve the situation of epilepsy patients
2016-05-29, ptp20160529001 Health/Medicine, Sport/Events
Health policy "needs to prioritise chronic pain"
2016-05-24, ptp20160524011 Health/Medicine, Politics/Law
"Neurological expertise crucial to deal with devastating Zika consequences"
2016-05-01, ptp20160501002 Health/Medicine, Travel/Tourism

1 2 3 4 5 6 7 8 9 10 Next »